* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
None
What’s baking in the oven?
Potential IPOs:***
3 June: Reveille Resources has announced its intention to IPO onto AQSE. The strategy is focused on identifying and advancing uranium exploration opportunities in assets that have benefited from significant historical expenditure and technical work, but which may not have achieved full value realisation due to geopolitical, technological, financial, or historical factors. Reveille’s initial focus is on two historical uranium deposits in Lombardy, northern Italy. Pre-admission, Andrea Cattaneo, Ippolito Cattaneo, Ajax Resources PLC, and Zenith Energy Ltd. each hold 25% of the shares. The four pre-admission shareholders will be subject to a one-year lock-in and a subsequent one-year orderly market agreement. Expected Admission date 25th June.
17 March: Vista Parcs Group has announced its intention to IPO onto AIM. The newly incorporated entity is proposing to acquire a portfolio of 13 UK-based holiday and residential parks currently owned by Barney Group 2 Ltd (BG2) and operated by Baslow Parks Ltd. Deal details TBC and expected Admission date anticipated late June 2026.
Banquet Buffet****
London Stock Exchange: Main Market and AIM
Avingtrans 570p £203.41m (AVG.L)
The Company which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors announced a trading update regarding the financial year ended 31 May 2026. The Board reported that profit for the Period will be in line with market expectations and the Group has continued to secure strategically significant contract awards across its core nuclear and infrastructure markets, while also making encouraging progress in expanding its presence in adjacent growth sectors.
Built Cybernetics 1.55p £6.28m (BUC.L)
The Smart Buildings group reported interim results to 31 March 2026. Revenue from continuing operations decreased 4% to £9.9m. The trading loss increased to £0.5m against £0.1m in the year to 31 March 2025, which was in line with expectations. The Annualised Recurring Revenue from its own software increased 37% to £1.03m. The New Smart Cities / Smart Infrastructure business MapBI has been launched. On 5 May, £0.65m was raised at 1.5p with material investment by directors and employees. The focus is on creating a smart buildings group with a growing proportion of predictable, scalable and high-margin recurring revenues, supported by complementary professional services and the architecture capabilities of Aukett Swanke.
Coppa Collective 14.25p £24.94m (COPC.L)
The multi-format hospitality group announced its results for the 26-week period ended 29 March 2026. Group LFL sales grew 1.8%, with revenue of £25.0m (H1 2025: £24.7m), the loss before tax narrowed to £1.7m (H1 2025: £2.2m) and cash at bank was £2.6m (H1 2025: £6.0m), after funding the £11.25m acquisition of The Linwood Collection. The CEO noted the pressures facing the wider hospitality sector are well-publicised, so for their like-for-like growth to outpace the benchmark is a meaningful achievement.
Eco Buildings Group 11.75p £16.21m (ECOB.L)
The technology-led housing manufacturing Company announced that, following the completion of its recent £2.35m fundraising, and construction has commenced with immediate effect on its second-generation AI-enabled manufacturing platform at its production facility in Durres, Albania. Eco expects to have this second manufacturing line operational within Q4 of this year. Unlike conventional or first-generation modular systems, the second-generation platform is being developed around advanced automation architecture integrated with AI. The objective is to create one of the most advanced, continuously improving industrial housing manufacturing systems currently in development.
Light Science Technologies Holdings 1.80p £17.87m (LST.L)
The technology and manufacturing business provided an update on trading within its Passive Fire Protection division following the acquisition of RLUK Injection Ltd, owner of Injectaclad, the patented fire-resistant barrier system, on 14 April. The group currently has two passive fire protection installation projects in progress with a combined contract value of c.£390k to c.£775k depending on the extent of remediation required. The Company has secured additional Injectaclad material supply orders with a value of c.£475k from approved installation contractors within the Injectaclad network. Total Injectaclad material supply orders secured since completion of the acquisition now amount to c.£885k.
Pennant International Group 26.50p £12.38m (PEN.L)
The systems support software and training solutions Company reports the first sale of Auxilium GenS via its global partnership with Siemens to a North American digital engineering customer that supports defence, national security and space domain missions. This follows the agreement with Siemens Digital Industries Software to distribute Auxilium - GenS as part of its Teamcenter platform. This platform provides access to a global customer base and reinforces the strategy to scale Auxilium through high-quality partnerships. This early progress is a significant milestone, evidencing the commercial traction and substantial opportunity to build momentum.
TMT Investments (TMT.L) $2.80 $60.74m*
The venture capital Company investing in high-growth technology companies announced an update on the Company's portfolio. In the last few weeks, TMT disposed of a part of its shareholding in cloud storage platform Backblaze, Inc. for a total net cash consideration of US$4.65m. On 23 June, Backblaze announced a major 5-year agreement with CoreWeave, Inc. for US$335m. Backblaze's current share price represents an increase of US$17m in the fair value of TMT's investment in Backblaze, compared to the previous reported amount as of 31 December 2025. In line with TMT's prudent approach to valuing its portfolio investments, the Company expects to write down the value partially or fully of at least seven of its smaller investments as at the forthcoming 30 June 2026 period end for a total value currently estimated at approximately US$3m.
Thalia Therapeutics 0.65p £4.79m (THAT.L)
The biotechnology Company developing, conditional up innovative RNA-based therapeutics and delivery technologies announced the acquisitionon shareholder approval, of Sanmirna Therapeutics, Inc., a US Corporation which holds an exclusive licence for the intellectual property and know-how around miRisten an anti-microRNA-126 for the treatment of Acute Myeloid Leukaemia, for an initial consideration of £3.675m with deferred milestone payments worth up to an additional £13m. In conjunction with the Acquisition, the Company has conditionally raised £2.75m at 0.6p. The completion of the Acquisition will immediately transform Thalia into a clinical-stage therapeutics development company, thereby accelerating the Company's strategy of building a diversified RNA therapeutics pipeline.
Velocity Composites 13.0p £8.2m (VEL.L)
The supplier of composite material kits to aerospace announced the Company's unaudited results for the six months ended 30 April 2026. Revenue of £8.4m (H1 2025: £10.4m), a Loss before tax of £1.0m (H1 2025: £0.6m) and Cash at bank as at 30 April of £0.7m (31 October 2025: £0.4m) were reported. The current scheduled product mix will reduce H2 gross margins, therefore the Board now expects adjusted EBITDA to be approximately £0.5m for the full year and for cash to be impacted resulting in full year results below current market expectations.
Zinc Media Group 57.00p £16.32m (ZIN.L)
The television, brand and audio production Group announced that Zinc Distribution, the Group's international sales division, has secured several international sales for Brexit: A Very British Civil War, a major new two-part documentary produced by Brook Lapping. The series tells the inside story of the EU referendum on its tenth anniversary, drawing on first-hand accounts from those at the heart of both campaigns. Zinc Distribution has completed licensing agreements covering North America (BBC Select, including Canada and the Caribbean), BBC News Arabic, Persian, Ukraine and Russia, and RTE in Ireland. Further broadcaster agreements are expected shortly, with discussions ongoing across multiple territories.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
